NCT02072044 Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy Status UNKNOWN Phase PHASE2
NCT02030717 Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT02009449 A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02005614 A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection Status TERMINATED Phase NA
NCT01984242 A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01975831 A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab Status COMPLETED Phase PHASE1
NCT01924156 DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT01914263 Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection Status UNKNOWN Phase PHASE1
NCT01892059 Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy Status UNKNOWN Phase NA
NCT01890590 A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma Status RECRUITING Phase NA
NCT01865747 A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT01838720 Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage Status UNKNOWN Phase NA
NCT01836406 Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy Status COMPLETED Phase NA
NCT01829971 A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection Status TERMINATED Phase PHASE1
NCT01806064 Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2